Lite Strategy, Inc. (LITS): EPS (Diluted)
-$2.39
Year ended 2025-06-30
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-06-30 | -$2.39 | n/m | 2025-09-26, From 2024-07-01 |
| 2024-06-30 | $2.67 | n/m | 2025-09-26, From 2023-07-01 |
| 2023-06-30 | -$4.78 | n/m | 2024-09-19, From 2022-07-01 |
| 2022-06-30 | -$9.99 | n/c | 2023-09-26, From 2021-07-01 |
| 2021-06-30 | -$0.60 | n/m | 2022-09-08, From 2020-07-01 |
| 2020-06-30 | -$0.52 | n/m | 2022-09-08, From 2019-07-01 |
| 2019-06-30 | -$0.75 | n/m | 2022-05-23, From 2018-07-01 |
| 2018-06-30 | -$0.97 | n/m | 2020-09-09, From 2017-07-01 |
| 2017-06-30 | $0.07 | n/m | 2019-08-28, From 2016-07-01 |
| 2016-06-30 | -$0.61 | n/m | 2018-08-30, From 2015-07-01 |
| 2015-06-30 | -$1.16 | n/a | 2017-09-05, From 2014-07-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | 2025-06-30 | -$2.39 | n/m |
| Abbott Laboratories (ABT) | 2025-12-31 | $3.72 | -51.3% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $3.46 | n/m |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | -$0.05 | n/m |
| Eli Lilly & Co (LLY) | 2025-12-31 | $22.95 | +96.0% |
| Pfizer Inc (PFE) | 2025-12-31 | $1.36 | -3.5% |
| Johnson & Johnson (JNJ) | 2025-12-28 | $11.03 | +90.5% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $1.06 | +165.0% |
| Merck & Co., Inc. (MRK) | 2025-12-31 | $7.28 | +8.0% |
Compare LITS, ABT, BMY, TXMD side by side · Screen every company in Pharmaceutical Preparations ↗